Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: Analysis and results of an ongoing prospective multicentre study at 3 years

BJU International

Volumn 97, Issue 6, 2006, Pages 1229-1233

  Te, Alexis E ^a   Malloy, Terrence R ^b   Stein, Barry S ^c   Ulchaker, James C ^d   Nseyo, Unyime O ^e   Hai, Mahmood A ^f  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c BROWN UNIVERSITY   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^f Oakwood Annapolis Hospital   (United States)

Author keywords

BPH; KTP; Laser prostatectomy; Outcome; Photoselective vaporization; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENERGY; HUMAN; LASER; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHOTOSELECTIVE VAPORIZATION PROSTATECTOMY; PREDICTION; PRIORITY JOURNAL; PROSTATE; PROSTATE ADENOMA; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; RESIDUAL URINE; TREATMENT OUTCOME; URINARY TRACT OBSTRUCTION; VAPORIZATION;

AGED; AGED, 80 AND OVER; HUMANS; LASER SURGERY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; TREATMENT OUTCOME; UROLOGIC DISEASES;

EID: 33745183133     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06197.x     Document Type: Article

References (19)

1. Larson TR. Rationale and assessment of minimally invasive approaches to benign prostatic hyperplasia therapy. Urology 2002 59: 12 6
2. Hill B, Belville W, Bruskewitz R et al. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol 2004 171: 2336 40
3. Lau KO, Li MK, Foo KT. Long-term follow-up of transurethral microwave thermotherapy. Urology 1998 52: 829 33
4. Floratos DL, Sonke GS, Francisca EA, Kiemeney LA, Debruyne FM, de la Rosette JJ. Long-term follow-up of laser treatment for lower urinary tract symptoms suggestive of bladder outlet obstruction. Urology 2000 56: 604 9
5. Barber NJ, Muir GH. High power KTP laser prostatectomy: the new challenge to transurethral resection of the prostate. Curr Opin Urol 2004 14: 21 5
6. Malek RS, Kuntzman RS, Barrett DM. High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol 2000 163: 1730 3
7. Malek RS, Kuntzman RS, Barrett DM. Photoselective potassium-titanyl- phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 2005 174: 1344 8
8. Te AE, Malloy TR, Stein BS et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States Multicenter Prospective Trial. J Urol 2004 172: 1404 8
9. Bhatta KM. Lasers in urology. Lasers Surg Med 1995 16: 312 30
10. Manyak MJ, Aulisi GP. Free-beam and contact laser ablation of benign prostatic hyperplasia with the KTP/Nd: YAG laser: efficacy and versatility. World J Urol 1995 13: 104 8
11. Carter A, Sells H, Speakman M, Ewings P, MacDonagh R, O'Boyle P. A prospective randomized controlled trial of hybrid laser treatment or transurethral resection of the prostate, with a 1-year follow-up. BJU Int 1999 83: 254 9
12. Langley SE, Gallegos CR, Moisey CU. A prospective randomized trial evaluating endoscopic Nd:YAG laser prostate ablation with or without potassium titanyl phosphate (KTP) laser bladder neck incision. Br J Urol 1997 80: 880 4
13. Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. High-power potassium-titanyl-phosphate photoselective vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 2004 64: 1155 9
14. Bachmann A, Ruszat R, Wyler S et al. Photoselective vaporization of the prostate: the Basel experience after 108 procedures. Eur Urol 2005 47: 798 804
15. Bachmann A, Schürch L, Ruszat R et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-center study of perioperative morbidity and early functional outcome. Eur Urol 2005 48: 965 72
16. Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T. High power (80W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005 173: 158 60
17. Tan AH, Gilling PJ, Kennett KM, Fletcher H, Fraundorfer MR. Long-term results of high-power holmium laser vaporization (ablation) of the prostate. BJU Int 2003 92: 707 9
18. Mottet N, Anidjar M, Bourdon O et al. Randomized comparison of transurethral electroresection and holmium: YAG laser vaporization for symptomatic benign prostatic hyperplasia. J Endourol 1999 13: 127 30
19. Tooher R, Sutherland P, Costello A, Gilling P, Rees G, Maddern G. A systematic review of holmium laser prostatectomy for benign prostatic hyperplasia. J Urol 2004 171: 1773 81